SERA PROGNOSTICS, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
SERA PROGNOSTICS, INC. (SERA) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $125.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-12
- SERA PROGNOSTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $58.00K, a 61.84% decline year-over-year.
- SERA PROGNOSTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $67.00K, a 55.03% decline year-over-year.
- SERA PROGNOSTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $66.00K, a 54.79% decline year-over-year.
- SERA PROGNOSTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $125.00K, a 12.59% decline year-over-year.
- SERA PROGNOSTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $492.00K, a 13.23% decline from fiscal 2024.
- SERA PROGNOSTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $567.00K, a 7.79% increase from fiscal 2023.
- SERA PROGNOSTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $526.00K, a 13.85% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $462.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $125.00K 10-Q · filed 2026-08-12 | $191.00K derived: sum of 3 quarters · filed 2026-08-12 | $316.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $67.00K 10-Q · filed 2026-05-06 | $133.00K derived: sum of 2 quarters · filed 2026-05-06 | $258.00K derived: sum of 3 quarters · filed 2026-05-06 | $410.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $191.00K derived: sum of 2 quarters · filed 2026-03-18 | $343.00K derived: sum of 3 quarters · filed 2026-08-12 | $492.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $277.00K derived: sum of 2 quarters · filed 2026-08-12 | $426.00K 10-Q · filed 2025-11-13 | $572.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $152.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $301.00K 10-Q · filed 2026-08-12 | $447.00K derived: sum of 3 quarters · filed 2026-08-12 | $590.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $149.00K 10-Q · filed 2026-05-06 | $295.00K derived: sum of 2 quarters · filed 2026-05-06 | $438.00K derived: sum of 3 quarters · filed 2026-05-06 | $578.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $289.00K derived: sum of 2 quarters · filed 2026-03-18 | $429.00K derived: sum of 3 quarters · filed 2026-03-18 | $567.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $143.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $283.00K derived: sum of 2 quarters · filed 2025-11-13 | $421.00K 10-Q · filed 2025-11-13 | $556.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $278.00K 10-Q · filed 2025-08-06 | $413.00K derived: sum of 3 quarters · filed 2025-08-06 | $545.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $138.00K 10-Q · filed 2025-05-07 | $273.00K derived: sum of 2 quarters · filed 2025-05-07 | $405.00K derived: sum of 3 quarters · filed 2025-05-07 | $536.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $267.00K derived: sum of 2 quarters · filed 2025-03-19 | $398.00K derived: sum of 3 quarters · filed 2025-03-19 | $526.00K 10-K · filed 2025-03-19 |
| 2023-09-30 | $132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $263.00K derived: sum of 2 quarters · filed 2024-11-06 | $391.00K 10-Q · filed 2024-11-06 | $516.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $131.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $259.00K 10-Q · filed 2024-08-07 | $384.00K derived: sum of 3 quarters · filed 2024-08-07 | $498.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $128.00K 10-Q · filed 2024-05-08 | $253.00K derived: sum of 2 quarters · filed 2024-05-08 | $367.00K derived: sum of 3 quarters · filed 2024-05-08 | $479.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $239.00K derived: sum of 2 quarters · filed 2024-03-20 | $351.00K derived: sum of 3 quarters · filed 2024-03-20 | $462.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $226.00K derived: sum of 2 quarters · filed 2023-11-08 | $337.00K 10-Q · filed 2023-11-08 | $337.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $223.00K 10-Q · filed 2023-08-09 | $223.00K derived: sum of 3 quarters · filed 2023-08-09 | |
| 2022-03-31 | $111.00K 10-Q · filed 2023-05-10 | $111.00K derived: sum of 2 quarters · filed 2023-05-10 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 10-K · filed 2023-03-22 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |